BIOMARIN PHARMACEUTICAL INC Insider Trading for April 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for April 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 82.15 | 11,059 | 908,497 | 62,543 | 73.6 K to 62.5 K (-15.03 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 112,500 | |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 122,500 | |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.29 | 10,000 | 822,887 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.58 | 10,000 | 825,811 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 82.15 | 11,059 | 908,497 | 62,543 | 73.6 K to 62.5 K (-15.03 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 112,500 | |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 122,500 | |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.29 | 10,000 | 822,887 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.58 | 10,000 | 825,811 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 132,500 | |
| Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.65 | 10,000 | 836,458 | 290,031 | 300 K to 290 K (-3.33 %) |
| Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
| Apr 19 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 38.59 | 3,750 | 144,713 | 0 | |
| Apr 19 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 85.00 | 3,750 | 318,750 | 14,860 | 18.6 K to 14.9 K (-20.15 %) |
| Apr 19 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 38.59 | 3,750 | 144,713 | 18,610 | 14.9 K to 18.6 K (+25.24 %) |
| Apr 09 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 107,000 | |
| Apr 09 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 290,031 | 289 K to 290 K (+0.35 %) |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 80.12 | 2,119 | 169,774 | 52,914 | 55 K to 52.9 K (-3.85 %) |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 108,000 | |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 289,031 | 288 K to 289 K (+0.35 %) |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 6,650 | 249,109 | 20,681 | |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 3,350 | 88,742 | 1,875 | |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 80.12 | 6,650 | 532,798 | 156,676 | 163.3 K to 156.7 K (-4.07 %) |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 6,650 | 249,109 | 163,326 | 156.7 K to 163.3 K (+4.24 %) |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 80.12 | 3,350 | 268,402 | 156,676 | 160 K to 156.7 K (-2.09 %) |
| Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 3,350 | 88,742 | 160,026 | 156.7 K to 160 K (+2.14 %) |